Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCR | P30988 | 3/20 | 0.54 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.53 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.53 |
| ▸ | GLP1R | P43220 | 13/20 | 0.52 |
| ▸ | SCTR | P47872 | 1/20 | 0.52 |
| ▸ | GCGR | P47871 | 4/20 | 0.49 |
| ▸ | PTH1R | Q03431 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29994110 | 0.95 | CALCR (0.58) | CALCRCRHR1CRHR2GLP1RSCTR | |
| SCHEMBL29726691 | 0.94 | CALCR (0.60) | CALCRCRHR1CRHR2GLP1RSCTR | |
| SCHEMBL30778184 | 0.94 | CALCR (0.60) | CALCRCRHR1CRHR2GLP1RSCTR | |
| SCHEMBL29880436 | 0.94 | CALCR (0.60) | CALCRCRHR1CRHR2GLP1RSCTR | |
| SCHEMBL30358158 | 0.92 | CALCR (0.57) | CALCRCRHR1CRHR2GLP1RSCTR | |
| SCHEMBL31265506 | 0.91 | CALCR (0.60) | CALCRCRHR1CRHR2GLP1RSCTR | |
| SCHEMBL30567705 | 0.89 | CALCR (0.65) | CALCRCRHR1CRHR2GLP1RSCTR | |
| SCHEMBL30974478 | 0.89 | GLP1R (0.49) | CALCRCRHR1CRHR2GLP1RSCTR | |
| SCHEMBL31139979 | 0.88 | GLP1R (0.66) | GLP1RSCTRGCGR | |
| SCHEMBL29777814 | 0.88 | CALCR (0.51) | CALCRCRHR1CRHR2GLP1RSCTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109310727-B | Conditionally active heterodimeric polypeptides and methods of use thereof | 加利福尼亚大学董事会 | 2022-09-27 | — | — | CN | claimed |
| CN-116334113-A | Conditionally active heterodimeric polypeptides and methods of use thereof | 加利福尼亚大学董事会 | 2023-06-27 | — | — | CN | disclosed |
| CN-113651870-B | Small molecule modified short peptide for promoting tissue repair and regeneration after trauma and application thereof | 暨南大学 | 2023-06-13 | — | — | CN | disclosed |
| CN-109310727-B | Conditionally active heterodimeric polypeptides and methods of use thereof | 加利福尼亚大学董事会 | 2022-09-27 | — | — | CN | disclosed |
| US-20220213452-A1 | CONDITIONALLY ACTIVE HETERODIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-07-07 | — | — | US | disclosed |
| US-20220041687-A1 | A GROUP OF CHIMERIC ANTIGEN RECEPTORS (CARS) | ST. ANNA KINDERKREBSFORSCHUNG (AT) | 2022-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220041687-A1 | A GROUP OF CHIMERIC ANTIGEN RECEPTORS (CARS) | CARS1, CD74, HAVCR2 | CALCR 625/4885CRHR1 903/4885CRHR2 1133/4885 |
| US-20220213452-A1 | CONDITIONALLY ACTIVE HETERODIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF | CPB2, AGBL2, IAPP | CALCR 2590/4885CRHR1 3032/4885CRHR2 1902/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.